Rani Therapeutics To Present Abstract On RT-102 At The 2023 Annual Meeting Of The American Society For Bone And Mineral Research
Portfolio Pulse from Benzinga Newsdesk
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) announced it will present an abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research. The presentation will detail the daily administration of an oral robotic pill (RT-102) that safely and reliably delivers Teriparatide with high bioavailability in women volunteers, based on a Phase I study.
October 12, 2023 | 8:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rani Therapeutics' presentation on RT-102 at a major conference could potentially increase visibility and interest in the company's products, potentially impacting its stock positively.
Presentations at major conferences often lead to increased visibility and interest in a company's products. If the presentation is well-received, it could potentially lead to increased investor confidence and a positive impact on the company's stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100